Liofilchem - Antibiotic Disk Interpretative Criteria and Quality Control - F14013 - Rev.7 / 20.02.2013



Similar documents
Product Catalogue 2015 Clinical and Industrial Microbiology

Date: November 30, 2010

Drug Use Review. Edward Cox, M.D. Director Office of Antimicrobial Products

ANTIMICROBIAL AGENT CLASSES AND SUBCLASSES

British Society for Antimicrobial Chemotherapy

Determination of minimum inhibitory concentrations. Jennifer M. Andrews* Department of Microbiology, City Hospital NHS Trust, Birmingham B18 7QH, UK

HUSRES Annual Report 2010 Martti Vaara

How To Treat Mrsa From A Dead Body

HUSRES Annual Report 2008 Martti Vaara.

HUSRES Annual Report 2015

How To Treat Mrsa In Finnish

Dosing information in renal impairment

The 14th EURL-AR Proficiency Test - enterococci, staphylococci and E. coli Lina Cavaco Susanne Karlsmose Rene S. Hendriksen Frank M.

for Extended Stability Parenteral Drugs Third Edition Caryn M. Bing, R.Ph., M.S., FASHP Editor

Version 11.1 May 2012

Helsingin ja Uudenmaan alueen herkkyystilastoja

SEA-HLM-415 Distribution: General. Establishment of national laboratory-based surveillance of antimicrobial resistance

BD Sensi-Disc Susceptibility Test Discs

Version 12 May BSAC Methods for Antimicrobial Susceptibility Testing. All enquiries to: Mandy Wootton.

Helsingin ja Uudenmaan alueen herkkyystilastoja

Antibiotikaanvändning

Received 4 July 2010; returned 10 August 2010; revised 27 September 2010; accepted 30 September 2010

OXOiD KÜLTÜR BESİYERLERİ

Received 22 March 2006/Returned for modification 2 May 2006/Accepted 14 September 2006

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

Appropriate Treatment for Children with Upper Respiratory Infection

Urinary Tract Infections

Antimicrobial Therapy. Otolaryngology Head and Neck Surgery

FORMULARY. (List of Covered Drugs) Molina Dual Options Medicare-Medicaid Plan

bactericidal Gram+ streptococci, enterococci, meningococci, treponema pallidum (syphilis), most anaerobes poor activity against Gram- rods

Oscar E. Guzman, PharmD, BCPS

ORIGINAL ARTICLE /j x

AETNA BETTER HEALTH OF OHIO a MyCare Ohio plan

OXOID FİYAT LİSTESİ ÜRÜN AÇIKLAMASI

The 11 th EURL-AR Proficiency Testing Salmonella and Campylobacter Susanne Karlsmose Lina M. Cavaco Rene S. Hendriksen Frank M.

Antimicrobial Activity and Spectrum of PPI-0903M (T-91825), a Novel Cephalosporin, Tested against a Worldwide Collection of Clinical Strains

SHEA Position Paper. Vol. 18 No. 4 INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY 275

CODE NO. PRODUCT NAME METHODOLOGY PACK SIZE HEPATITIS C

ANNUAL REPORT ON STAPHYLOCOCCUS AUREUS BACTERAEMIA CASES IN DENMARK 2008 (part I)

ANNUAL REPORT ON STAPHYLOCOCCUS AUREUS BACTERAEMIA CASES IN DENMARK 2009 (part I)

Key words: antibiotics, antiseptics, resistance, burns, comlications, microorganisms.

2015 Formulary (List of Covered Drugs)

Practice Guidelines. Updated Guideline on Diagnosis and Treatment of Intra-abdominal Infections

PROJECT LIST GENERIC PRODUCTS

Welcome. Quality. Ethical Statement. Website This Catalogue is available electronically from our website:

Treatment of Fever and Infection in Children with Transfusion Dependent Thalassaemia

Plasmidic Extended-Spectrum -Lactamases in Vibrio cholerae O1 El Tor Isolates in Argentina

Clinical Practice Guidelines for Antimicrobial Prophylaxis in Surgery

How To Get A Drug Plan To Pay For A Prescription From Acpa

A baseline survey of antimicrobial resistance in bacteria from selected New Zealand foods,

ANTIBIOTICS IN SEPSIS

Beta-lactam antibiotics - Cephalosporins

NewYork-Presbyterian Hospital Sites: Columbia University Medical Center Guideline: Medication Use Manual Page 1 of 12

Antimicrobial Susceptibility Patterns of Common and Unusual Enterococcus species Isolated from Clinical Specimens

Penetration of Antimicrobial Agents into the Prostate

Rapid antimicrobial susceptibility testing of clinical isolates by digital time-lapse microscopy

PRMCE ANTI-INFECTIVES SELECTION GUIDELINE FOR ADULTS

INTRAVENOUS DRUG QUICKGUIDE

NEW SCHEDULE H1 INSERTED IN DRUGS AND COSMETICS RULES :

Urinary tract infections caused by extended spectrum β-lactamase (ESBL) producing Escherichia coli and Klebsiella pneumoniae

Prescription Drug Guide

CAP, HAP, VAP, & HCAP

Vancomycin. Beta-lactams. Beta-lactams. Vancomycin (Glycopeptide) Rifamycins (rifampin) MID 4

AAC Accepts, published online ahead of print on 20 August 2007 Antimicrob. Agents Chemother. doi: /aac

Optimizing Antimicrobial Susceptibility Test Reporting

Bacterial Infections Caused by Achromobacter xylosoxidans

Appendix M: Guidelines for the Prophylaxis and Management of Intraabdominal, Biliary, and Appendiceal Infections

Outpatient Parenteral Antimicrobial Therapy

May 2015 P&T Updates. Prior Authorization. Traditional. Formulary. Yes No. Formulary. Non Formulary. Non Formulary. Non Formulary

AMBULATORY SURGERY CENTERS ASTHMA AND RESPIRATORY ILLNESS

Disc Diffusion Susceptibility Methods

Objectives. Fluids. Sterile IV Techniques. How many of you have sterile compounding technique procedures at your institution?

Practice Guidelines for the Management of Bacterial Meningitis

Catalogue of technologies developed by Polish Research NON-CLINICAL RESEARCH UNITS

Treatment of skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus in adults

Magellan Rx Medicare Basic (PDP) 2016 Formulary. (List of Covered Drugs)

Antibiotics and Infectious Disease in Otolaryngology-HNS

Annual Report on Staphylococcus aureus Bacteraemia Cases 2006

Streptococcus pneumoniae IgG AB (13 Serotypes), MAID... 7

Antibacterial Drug Shortages From 2001 to 2013: Implications for Clinical Practice

IDSA GUIDELINES EXECUTIVE SUMMARY

The State of Therapeutics in Eye Care (Part I)

MARAN NethMap Consumption of antimicrobial agents and antimicrobial resistance among medically important bacteria in the Netherlands

MicroMD emr version 7.5

Rational Selection of Antimicrobials for Use in Horses

The Five Intravenous Antibiotics You Need to Know

A role for Propionibacterium acnes in post-operative orthopedic implant infections Katherine P. Lemon, MD PhD Joint ID Conference April 28, 2003

Complicated urinary tract infections: practical solutions for the treatment of multiresistant Gram-negative bacteria

Note. 2.0 Background. 1.0 Introduction RECOMMENDATION

ANNUAL REPORT ON STAPHYLOCOCCUS AUREUS BACTERAEMIA CASES IN DENMARK 2009

California Gonorrhea Treatment Guidelines

Intra-abdominal abdominal Infections

Cefuroxime apollo

Gram negatif bakterilerde GSBL üretiminin üç farklı yöntemle araştırılması ve antibiyotik direnç oranları ÖZET

PLEASE READ: THIS DOCUMENT CONTAINS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN.

National Surveillance of Invasive Streptococcus pneumoniae and Streptococcus pyogenes In Canada

Culture and sensitivity pattern of micro-organism isolated from diabetic foot infections in a tertiary care hospital

Beta-Lactamase Encoding Gene Among Extended Spectrum B-Lactamase Positive Wound Isolates of Pseudomonas

CMT - Copan Milk Test

Transcription:

Liofilchem Antibiotic Disk Interpretative Criteria and Quality Control F0 Rev.7 /.02. Amikacin AK Amoxicillin + Clavulanic acid AUG (+) ATCC 352 Coagulasenegative staphylococci Amoxicillin + Clavulanic acid AUG 3 () H.influenzae Ampicillin AMP 2 S. saprophyticus L. monocytogenes Ampicillin AMP βhemolytic group Ampicillin + Sulbactam AMS (+) Azithromycin AZM βhemolytic group H.influenzae H.influenzae ATCC 352 ATCC 496 ATCC 352 ATCC 496 36 35 6 36 37 8 ATCC 3 ATCC 2 ATCC 352 ATCC 3 ATCC 2 ATCC 496 6 Azlocillin AZL 75 Aztreonam ATM Carbenicillin CAR 0 Cefaclor CEC ATCC 49766 ATCC 496 36 38 32 ATCC 352 ATCC 496 Cefadroxil CDX 36 1

Liofilchem Antibiotic Disk Interpretative Criteria and Quality Control F0 Rev.7 /.02. Cefamandole MA Cefazolin KZ Cefepime FEP βhemolytic group Cefixime CFM 5 Cefoperazone CFP 75 Cefotaxime CTX βhemolytic group 34 ATCC 496 ATCC 496 ATCC 496 ATCC 496 ATCC 496 ATCC 496 32 34 35 37 3746 35 33 3745 34 33 35 39 3848 39 Cefotaxime CTX 5 Cefotetan CTT Cefpodoxime PX Cefoxitin FOX and S. lugdunensis Coagulasenegative staphylococci except S. lugdunensis ATCC 496 ATCC 496 ATCC 496 ATCC 496 34 36 3543 34 3341 S. lugdunensis and S. saprophyticus Coagulasenegative staphylococci ATCC 496 ATCC 496 ATCC 496 37 37 35 33 34 35 35 34 2

Liofilchem Antibiotic Disk Interpretative Criteria and Quality Control F0 Rev.7 /.02. Cefprozil CPR ATCC 49766 ATCC 496 33 32 Ceftaroline CPT 5 Ceftazidime CAZ B. cepacia ATCC 496 32 35 3543 Ceftazidime CAZ Ceftibuten CTB Ceftizoxime CZX Ceftriaxone CRO βhemolytic group Cefuroxime CXM (Parenteral) (Oral) (Parenteral) (Oral) (Parenteral (Oral) Cephalothin KF 38 35 34 ATCC 496 ATCC 496 ATCC 496 ATCC 496 ATCC 49766 ATCC 496 ATCC 496 35 36 36 35 39 41 34 35 39 3951 35 35 36 3341 37 32 Cefuroxime iv Cefuroxime Oral (axetil) (axetil) ATCC 3 ATCC 496 ATCC 496 35 36 35 38 3341 34 3

Liofilchem Antibiotic Disk Interpretative Criteria and Quality Control F0 Rev.7 /.02. Chloramphenicol C βhemolytic group ATCC 496 Cinoxacin CIN 0 32 Ciprofloxacin CIP 5 other than S. typhi and extraintestinal Salmonella spp. S. typhi and extraintestinal Salmonella spp. N. Meningitidis Clarithromycin CLR βhemolytic group Clindamycin CD 2 βhemolytic Group Viridans Group 41 35 40 3334 32 Colistin sulfate CS Doripenem DOR Doxycycline DXT 1 9 ATCC 496 ATCC 496 ATCC 496 ATCC 496 ATCC 496 40 20 33 3442 4858 32 35 3342 35 38 34 C. coli ATCC 3 ATCC 496 ATCC 3 ATCC 496 ATCC 33560 ATCC 3 ATCC 496 ATCC 496 38 40 33 39 3442 35 35 37 32 4

Liofilchem Antibiotic Disk Interpretative Criteria and Quality Control F0 Rev.7 /.02. Ertapenem ETP Erythromycin E βhemolytic group Fosfomycin (includes G6P) FOS 0 Fusidic acid FC Gatifloxacin GAT 5 βhemolytic group Gentamicin CN 38 3437 33 ATCC 49766 ATCC 496 ATCC 496 ATCC 496 ATCC 496 ATCC 496 36 33 35 20 20 33 32 9 37 33 3341 4556 L. monocytogenes C. coli ATCC 496 ATCC 3 ATCC 496 ATCC 33560 36 34 33 32 35 ATCC 3 32 Coaugulasenegative staphylococci ATCC 3 Gentamicin CN ATCC 2 Imipenem IMI Kanamycin K 32 ATCC 2 ATCC 496 32 3442 5

Liofilchem Antibiotic Disk Interpretative Criteria and Quality Control F0 Rev.7 /.02. Levofloxacin LEV 5 S. maltophilia βhemolytic group ATCC 496 37 Linezolid LNZ Linezolid LNZ βhemolytic group Lomefloxacin LOM Loracarbef LOR 38 37 ATCC 496 ATCC 496 ATCC 49766 ATCC 496 32 34 33 3341 4554 32 ATCC 3 ATCC 496 ATCC 3 ATCC 2 ATCC 496 Mecillinam MEC Meropenem MRP B. cepacia ATCC 496 34 37 33 35 L. monocytogenes 33 33 Methicillin MET 5 Mezlocillin MEZ 75 Minocycline MN B. cepacia S. maltophilia ATCC 496 ATCC 3 ATCC 496 37 38 34 33 38 34 33 6

Liofilchem Antibiotic Disk Interpretative Criteria and Quality Control F0 Rev.7 /.02. Moxifloxacin MOX 5 ATCC 496 35 35 39 ATCC 3 ATCC 496 Mupirocin MUP 0 ATCC 3 37 Nafcillin NAF 1 Nalidixic acid NA Netilmicin NET Coagulasenegative Staphylococci Netilmicin NET 20 21 Nitrofurantoin F 0 Nitrofurantoin F 0 Norfloxacin NOR Ofloxacin OFX 5 βhemolytic group Oxacillin OX 1 Penicillin G P IU βhemolytic group 47 46 ATCC 496 ATCC 496 ATCC 496 ATCC 496 ATCC 496 ATCC 496 ATCC 496 35 33 4351 37 34 ATCC 3 ATCC 3 ATCC 2 ATCC 496 ATCC 3 ATCC 496 ATCC 3 ATCC 496 35 35 33 35 33 36 ATCC 496 8 7

Liofilchem Antibiotic Disk Interpretative Criteria and Quality Control F0 Rev.7 /.02. Penicillin G P 1 IU (screen) L. monocytogenes Piperacillin PRL Piperacillin PRL 0 Piperacillin + Tazobactam TZP 1 (0+) ATCC 352 ATCC 352 33 36 33 3338 Piperacillin + Tazobactam TZP 36 (+6) Polymyxin B PB 0 IU QuinupristinDalfopristin QDA βhemolytic group Rifampicin RD 5 ATCC 496 ATCC 496 8 34 20 (for prophylaxis only) Spectinomycin SPC 0 ATCC 496 Streptomycin S Streptomycin S 0 Teicoplanin TEC ATCC 3 ATCC 496 ATCC 352 ATCC 352 ATCC 3 ATCC 2 ATCC 3 ATCC 496 ATCC 2 ATCC 496 69 9 36 32 8

Liofilchem Antibiotic Disk Interpretative Criteria and Quality Control F0 Rev.7 /.02. Telithromycin TEL Tetracycline TE βhemolytic group Ticarcillin TC 75 Ticarcillin + Clavulanic acid TTC 85 (75+) 38 37 Tigecycline TGC Tobramycin TOB Trimethoprim TM 5 Trimethoprim + Sulfamethoxazole SXT (1.+.75) B. cepacia S. maltophilia ATCC 496 ATCC 496 ATCC 496 ATCC 352 ATCC 352 ATCC 496 ATCC 496 ATCC 496 33 42 6 37 9 40 32 32 C. coli Coagulasenegative staphylococci S. maltophilia L. monocytogenes ATCC 496 ATCC 3 ATCC 496 ATCC 33560 33 34 34 38 ATCC 3 ATCC 2 ATCC 496 ATCC 3 ATCC 3 ATCC 2 ATCC 3 ATCC 2 ATCC 496 32 32 34 34 9

Liofilchem Antibiotic Disk Interpretative Criteria and Quality Control F0 Rev.7 /.02. Vancomycin VA 5 Vancomycin VA βhemolytic Group Viridans Group ATCC 496 ATCC 2 ATCC 496 Refer to tables of clinical breakpoints. References 1. M0S. Performance Standards for Antimicrobial Susceptibility Testing, January. 2.. Breakpoint tables for interpretation of MICs and zone s, Version 3.0, January. 3. Routine internal quality control as recommended by, Version 3.0, January. 4. Extended quality control as recommended by, Version 1.0, January Disclaimer The present Antibiotic Disk Interpretative Criteria and Quality Control table might be out of date. Check online for the latest update: http://www.liofilchem.net/pdf/disc/disc_interpretative_table.pdf The present Antibiotic Disk Interpretative Criteria and Quality Control table does not replace the official documents by and. LIOFILCHEM s.r.l. Via Scozia zona ind.le, 640 Roseto degli Abruzzi (Te) Italy Tel. +39 08589745 Fax +39 085893 www.liofilchem.net liofilchem@liofilchem.net IVD F0 Rev.7 /.02.